Is oral rapamycin useful in preventing coronary stent restenosis? A randomized study

被引：0
|
作者：
Sarmiento, Ricardo A.
Cherro, Alejandro
Szarfer, Jorge L.
Lynch, Angeles Videla
Solerno, Raul
Grinfeld, Diego
Ferrari, Pablo
Campo, Anibal
机构：
[1] Hosp Frances Riosa, Buenos Aires, DF, Argentina
[2] Hosp Argerich, Buenos Aires, DF, Argentina
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 98卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：198M / 198M
页数：1
相关论文
共 50 条
  • [1] Oral rapamycin to prevent human coronary stent restenosis:: A pilot study
    Guarda, E
    Marchant, E
    Fajuri, A
    Martínez, A
    Morán, S
    Mendez, M
    Uriarte, P
    Valenzuela, E
    Lazen, R
    AMERICAN HEART JOURNAL, 2004, 148 (02) : 341
  • [2] Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis - The prospective, randomized oral rapamycin in Argentina (ORAR II) study
    Rodriguez, AE
    Granada, JF
    Rodriguez-Alemparte, M
    Vigo, CF
    Delgado, J
    Fernandez-Pereira, C
    Pocovi, A
    Rodriguez-Granillo, AM
    Schulz, D
    Raizner, AE
    Palacios, I
    O'Neill, W
    Kaluza, GL
    Stone, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1522 - 1529
  • [3] Efficacy and tolerability of oral rapamycin to prevent restenosis after coronary stent implantation: The prospective, randomized ORAR II study
    Rodriguez, AE
    Rodriguez-Alemparte, M
    Fernandez-Pereira, C
    Pocovi, A
    Tronge, J
    Kaluza, G
    Raizner, A
    Stone, GW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 70A - 70A
  • [4] A DOUBLE BLIND RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF BINDARIT IN PREVENTING CORONARY STENT RESTENOSIS
    Colombo, Antonio
    Limbruno, Ugo
    Lettieri, Corrado
    Lioy, Ernesto
    Guglielmotti, Angelo
    Calabresi, Marco
    Valgimigli, Marco
    Pierucci, Daniela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E11 - E11
  • [5] Oral rapamycin for the prevention of in-stent restenosis
    Mehran, R
    Marx, S
    Kesanakurthy, S
    Adamian, Y
    Aboufares, A
    Mousse, I
    Kokolis, S
    Collins, M
    New, G
    Polena, S
    Cosico, J
    Lansky, AJ
    Moses, JW
    Stone, GW
    Leon, MB
    Dangas, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 74A - 74A
  • [6] Coronary restenosis prevention with a rapamycin coated stent
    Rensing, B
    Vos, J
    Smits, P
    Foley, D
    van den Brand, M
    de Gies, W
    de Feijter, P
    Serruys, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 47A - 47A
  • [7] The Preventing Restenosis Effects of Rapamycin and Paclitaxel Blending Eluting Stent on Susscrota Domestica Coronary Artery
    Kong Hongliang
    Qi Guoxian
    Li Zhanquan
    Guan Ruming
    CIRCULATION, 2010, 122 (02) : E63 - E63
  • [8] Pillot study with an optimized oral rapamycin protocol for the prevention of in-stent restenosis
    Chaves, A
    Vaz, VD
    Tinoco, JE
    Abizaid, A
    Mattos, LA
    Feres, F
    Staico, R
    Tanajura, LF
    Centemero, M
    Abizaid, AS
    Pinto, I
    Seixas, AC
    Sousa, A
    Sousa, JE
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 178L - 178L
  • [9] Oral versus stent-eluted rapamycin for the prevention of in-stent restenosis in de novo native coronary lesions
    Tinoco, JE
    Chaves, A
    Vaz, VD
    Abizaid, A
    Albertal, M
    Tanajura, LF
    Abizaid, AS
    Staico, R
    Feres, F
    Mattos, LA
    Sousa, AGMR
    Sousa, JE
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 27L - 27L
  • [10] Randomized drug-eluting stent comparision: rapamycin versus paclitaxel in coronary lesions prone to restenosis
    Medina, A
    de Lezo, JS
    Pan, M
    Romero, M
    Delgado, A
    Segura, J
    Segura, F
    Melian, F
    EUROPEAN HEART JOURNAL, 2004, 25 : 317 - 317
12345